Task: Answer the MCQ question.
Query: Which compound exhibits a -1.221\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) C#CCn1c(O)c(N=NC(=O)C(O)c2ccccc2)c2ccccc21
b) CC1(C)Cc2c(sc3ncn4c(=S)[nH]nc4c23)CO1
Answer: a. C#CCn1c(O)c(N=NC(=O)C(O)c2ccccc2)c2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C#CCn1c(O)c(N=NC(=O)C(O)c2ccccc2)c2ccccc21
C#CCn1c(O)c(N=NC(=O)C(O)c2ccccc2)c2ccccc21
2-hydroxy-N-(2-hydroxy-1-prop-2-ynylindol-3-yl)imino-2-phenylacetamide